Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma

A Japanese subgroup analysis from the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) was performed to evaluate the efficacy and safety outcomes of the Japanese population. In this Asian phase II study, darinaparsin was administered to 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Negoro, Eiju, Yamauchi, Takahiro, Fukuhara, Noriko, Yamamoto, Kazuhito, Uchida, Toshiki, Izutsu, Koji, Maruyama, Dai, Terui, Yasuhito, Nakajima, Hideaki, Ando, Kiyoshi, Suehiro, Youko, Choi, Ilseung, Kanemura, Nobuhiro, Nakamura, Nobuhiko, Yamamoto, Go, Maeda, Yoshinobu, Shibayama, Hirohiko, Nagahama, Fumiko, Sonehara, Yusuke, Nagai, Hirokazu, Tien, Hwei-Fang, Kwong, Yok-Lam, Kim, Won-Seog, Tobinai, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410617/
https://www.ncbi.nlm.nih.gov/pubmed/37380467
http://dx.doi.org/10.3960/jslrt.23005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410617/
https://www.ncbi.nlm.nih.gov/pubmed/37380467
http://dx.doi.org/10.3960/jslrt.23005

Ejemplares similares